mHealth Technology

Microwave radiofrequency is emerging as the most promising approach for remote care of congestive heart failure and significantly reducing hospital admissions and re‑admissions.

LifeWave has developed a broad base of intellectual property and expertise in a new medical imaging modality that uses very low power UWB radio frequency (RF) energy. The technology is similar in concept to ultrasound but uses radio frequency instead of sound energy.

The LifeWave UWB sensor emits very low energy (similar to Bluetooth energy levels) which propagate into the human body. As the energy enters the body, small amounts of the incident energy are reflected back to a sensing device. The reflections are primarily the result of the differences in dielectric properties of the underlying tissues and organs. The reflected energy is then received and processed using signal processing algorithms to extract information on the type, location, size, and relative movement of the illuminated tissues and organs.

The technology can be designed to operate either on-body or off-body. On-body usage will provide internal bodily assessments, while off-body usage is limited to assessment of physiological processes that result in activity at the skin surface, which is sufficient for cardiac rate and respiratory rate.

The LifeWave technology is safe for full-time usage and skin contact and meets all FDA human safety and Federal Communications Commission (FCC) regulations governing human RF exposure.